Navigation Links
Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
Date:12/21/2009

FRAZER, Pa., Dec. 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has extended the action date to March 29, 2010, for its review of the supplemental New Drug Application (sNDA) for NUVIGIL® (armodafinil) Tablets [C-IV]. The sNDA is for the indication of improved wakefulness in patients with excessive sleepiness associated with jet lag disorder due to eastbound travel.

"We will continue to work closely with the FDA to assist them in completing their review of our application in a timely manner and do not anticipate any further delays beyond the March 29, 2010, action date," said Dr. Lesley Russell, Chief Medical Officer at Cephalon. "We remain excited about this opportunity as there are no medications approved by the FDA to treat excessive sleepiness associated with eastbound jet lag disorder."

This sNDA for NUVIGIL was filed with the FDA on June 29, 2009, and given the action date of December 29, 2009, under the Prescription Drug User Fee Act (PDUFA). The company submitted additional information within 90 days of the assigned action date. Subsequently, the FDA informed the company that the agency required more time for a full review of the submission and, therefore, would extend the action date by three months.

About NUVIGIL

NUVIGIL, the longer-lasting isomer of modafinil, was launched in the United States in June 2009. It is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. NUVIGIL is not approved as a treatment for jet lag disorder or its associated symptoms. The NUVIGIL label includes a bolded warning for serious or life-threatening rash, including Stevens-Johnson Syndrome, th
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
2. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
3. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
4. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
5. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
6. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
7. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
8. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
9. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
10. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
11. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Pa. , Sept. 17, 2014  Auxilium Pharmaceuticals, ... company, today confirmed that Auxilium has received an unsolicited, ... ENDP ) to acquire all of the outstanding shares ... per share in cash and Endo stock, subject to ... the unsolicited, non-binding proposal that Auxilium received from Endo ...
(Date:9/16/2014)... Massachusetts , 17 settembre 2014 ... annunciato oggi il lancio in Europa del Tomcat, ... Tomcat è una piattaforma multifunzionale completamente automatizzata, progettata ... le inefficienze ed i rischi di errore legati ... automazione dello strumento Tomcat di Hologic riduce il ...
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
Breaking Medicine Technology:Auxilium Responds To Unsolicited Proposal From Endo International 2Auxilium Responds To Unsolicited Proposal From Endo International 3Auxilium Responds To Unsolicited Proposal From Endo International 4Auxilium Responds To Unsolicited Proposal From Endo International 5Auxilium Responds To Unsolicited Proposal From Endo International 6Auxilium Responds To Unsolicited Proposal From Endo International 7Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
... GlaxoSmithKline (NYSE: GSK ) confirmed today that a joint ... allow Avandia to remain on the market. Committee members voted for recommendations ... label with additional warnings and restrictions (20) to withdrawal from the U.S. ... , ...
... Services announced today  that the American Board of Radiology (ABR) has qualified ... therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of ... , With ... audit of their beam data through the use of a web portal: ...
Cached Medicine Technology:GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 2GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 3GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 4eDataAudit Receives Approval from the American Board of Radiology 2
(Date:9/17/2014)... PROVIDENCE, R.I. [Brown University] Right now no one ... with bipolar disorder, but in a new article in ... survey responses they gathered from scores of people with ... suggests is that yoga can be a substantial help, ... no scientific literature on hatha yoga for bipolar disorder," ...
(Date:9/17/2014)... 2014 Fresh off their High Times ... its support of The Silver Tour, an educational non-profit ... many benefits of medical marijuana. , Florida Buds, a ... marijuana dispensary and treatment center, donated $1,000.00 ... to launch a statewide radio campaign in advance of ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 DMG ... Ed Begley, Jr., scheduled to broadcast on Wednesday, ... Discovery Channel. , In this episode, Innovations will ... of Freedom’s mission to provide each client the ... spiritual well being; using the principles of Care, ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Angeldress.co.uk ... kinds of graceful special occasion outfits for worldwide clients. ... officials are thinking of opening the first flagship retail ... fashion industry. Recently, the company has unveiled its new ... promotion. , All its new products are offered ...
(Date:9/17/2014)... For electronic publishing expert eBooks2go, working with ... a miraculous connection and precision timing. This experienced wordsmith ... over the past three decades, Ms. Wixom has produced ... it rather tedious to expand her readership inside a ... call, an anniversary, and a second-place trophy changed all ...
Breaking Medicine News(10 mins):Health News:Survey finds benefits, risks of yoga for bipolar disorder 2Health News:Survey finds benefits, risks of yoga for bipolar disorder 3Health News:Florida Buds Supports Silver Tour 2Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Angeldress.co.uk Is Planning To Open Its First Retail Store And Offering Big Savings On Amazing Wedding Dresses 2Health News:Versatile Author Wixom Forges Lasting Relationship with Digital Virtuoso eBooks2go 2Health News:Versatile Author Wixom Forges Lasting Relationship with Digital Virtuoso eBooks2go 3Health News:Versatile Author Wixom Forges Lasting Relationship with Digital Virtuoso eBooks2go 4
... have long thought that limiting the calories a person consumes ... cancers. But research using mice suggests// that body composition ... is key to reducing cancer risks. ,In ... important to controlling cancer risks than how many or how ...
... American biologist has developed a backpack that reduces the weight ... by Lawrence Rome, a biology professor at the University of ... emergency workers, reported UPI news wire. ,It uses ... the burden of weight. The cords suspend the load at ...
... to a study published in the the journal SLEEP, ... depressive symptoms// and comorbid anxiety disorders compared with children ... most effective care, parents of sleep-disturbed children are advised ... issue a referral to a sleep specialist for comprehensive ...
... marine snail have gotten an unprecedented look at brain mechanisms, ... creature are far from sluggish. ,At any given time ... as Aplysia, more than 10,000 genes are active, according to ... journal Cell. The findings suggest that acts of learning or ...
... In hemophilia, a mutated gene prevents the production of ... such genetic diseases, when they exist//, may consist of ... what if the body could be induced to begin ... the abilities that are lacking? ,Prof. Yair Reisner ...
... at Purdue University have used a new technique ... dangerous E. coli, without time-consuming// treatments usually required. ... DESI, could be used to create a new ... from food safety to homeland security, said R. ...
Cached Medicine News:Health News:Body Composition Is Key Player in Controlling Cancer Risks 2Health News:Link Between Insomnia and Hypersomnia, Depression in Children 2Health News:How Many Genes Does It Take to Learn? Lessons from Sea Slugs 2Health News:How Many Genes Does It Take to Learn? Lessons from Sea Slugs 3Health News:A Transplant in Time - Scientists ID Window for Tissue Transplant 2Health News:New Technique to Identify Bacteria for Food Safety 2Health News:New Technique to Identify Bacteria for Food Safety 3
... Multifunctional instrumentation, capable of ... tissue by means of ultra-sonic ... on organs, and, in particular, ... advantages of tissue-selection and non-traumatic ...
... expect from the long-established Selector Ultrasonic ... integrated circuitry and the small, ergonomic ... surgical techniques, ultrasonic surgery selectively dissects ... as nerves and blood vessels relatively ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 9.0 mm and length 7.5 mm....
Medicine Products: